Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study
- 7 October 1978
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 4 (4), 307-312
- https://doi.org/10.1002/ana.410040404
Abstract
The feasibility and toxicity of intrathecal lymphoid cell infusions in patients with glioma were examined in this study. Blood rich in lymphoid cells was obtained using the Haemonetics Model 30 cell separator; the lymphoid cells extracted were further purified on Ficoll‐Hypaque gradients. Four patients received a total of eighteen autologous lymphoid cell infusions, with between 1 × 106 and 5 × 109 lymphoid cells being infused on each occasion. No toxicity was observed, but the CSF glucose declined in 2 patients. In 1 patient examined at autopsy the lymphoid cells appeared to have gained access to the tumor bed as well as to the rest of the subarachnoid space.Keywords
This publication has 9 references indexed in Scilit:
- Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary reportCancer, 1977
- Toxicity kinetics and clinical potential of subarachnoid lymphocyte infusionsJournal of Neurosurgery, 1977
- A Standardized Technique for Efficient Platelet and Leukocyte Collection Using the Model 30 Blood ProcessorTransfusion, 1976
- ROSETTING TESTSThe Lancet, 1974
- Cell-mediated immunity and blocking factors in patients with tumours of the central nervous systemInternational Journal of Cancer, 1973
- Cell-bound antiglial immunity in patients with malignant tumors of the brainCellular Immunology, 1973
- DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORSThe Journal of Experimental Medicine, 1972
- Autoradiographic and fluorescence antibody studies of the human host immune response to gliomasNeurology, 1972
- LYMPHOCYTIC INFILTRATION IN GLIOMAS: EVIDENCE OF POSSIBLE HOST RESISTANCEBrain, 1971